|
ISR | Perspective Therapeutics, Inc. |
|
|
ISR | Perspective Therapeutics, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 2.25 |
| Leverage | 17.84% |
| Market Cap | $ 107.7m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -85.3m |
| Margin | -836.42% |